The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Neuroprotective action of resveratrol
Open accessAbstract
Low-to-moderate red wine consumption appeared to reduce age-related neurological disorders including macular degeneration, stroke, and cognitive deficits with or without dementia. Resveratrol has been considered as one of the key ingredients responsible for the preventive action of red wine since the stilbene displays a neuroprotective action in various models of toxicity. Besides its well documented free radical scavenging and anti-inflammatory properties, resveratrol has been shown to increase the clearance of beta-amyloid, a key feature of Alzheimer's disease, and to modulate intracellular effectors associated with oxidative stress (e.g. heme oxygenase), neuronal energy homeostasis (e.g. AMP kinase), program cell death (i.e. AIF) and longevity (i.e. sirtuins). This article summarizes the most recent findings on mechanisms of action involved in the protective effects of this multi target polyphenol, and discusses its possible roles in the prevention of various age-related neurological disorders. This article is part of a Special Issue entitled: Resveratrol: Challenges in translating pre-clinical findings to improved patient outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Brain energy metabolism: focus on Astrocyte-neuron metabolic cooperation
Bélanger, M., Allaman, I., & Magistretti, P. J. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.016 · Cited by 2,313
Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity
Calabrese, V., Mancuso, C., Calvani, M., Rizzarelli, E., Butterfield, D. A., & Giuffrida Stella, A. M. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2214 · Cited by 1,543
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Park, S.-J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.017 · Cited by 1,349
Mechanism of Human SIRT1 Activation by Resveratrol
Borra, M. T., Smith, B. C., & Denu, J. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501250200 · Cited by 1,065
Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061
Bioavailability of resveratrol
Walle, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05842.x · Cited by 1,051
Shibata, R., Sato, K., Pimentel, D. R., Takemura, Y., Kihara, S., Ohashi, K., Funahashi, T., Ouchi, N., & Walsh, K. (2005) · Nature Medicine · doi:10.1038/nm1295 · Cited by 982
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1
Pacholec, M., Bleasdale, J. E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R. S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088682 · Cited by 915
The amyloid hypothesis for Alzheimer’s disease: A critical reappraisal
Hardy, J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06181.x · Cited by 814
Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides
Marambaud, P., Zhao, H., & Davies, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508246200 · Cited by 749
SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling
Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L.-F., Kwon, H., Yi, S., Mucke, L., & Gan, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509329200 · Cited by 740
Resveratrol stimulates AMP kinase activity in neurons
Dasgupta, B., & Milbrandt, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610068104 · Cited by 723
Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications
Alarcón de la Lastra, C., & Villegas, I. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500022 · Cited by 703
Absorption of three wine-related polyphenols in three different matrices by healthy subjects
Goldberg, D. M., Yan, J., & Soleas, G. J. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00397-1 · Cited by 683
Vingtdeux, V., Giliberto, L., Zhao, H., Chandakkar, P., Wu, Q., Simon, J. E., Janle, E. M., Lobo, J., Ferruzzi, M. G., Davies, P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.060061 · Cited by 645
When NRF2 Talks, Who's Listening?
Wakabayashi, N., Slocum, S. L., Skoko, J. J., Shin, S., & Kensler, T. W. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3216 · Cited by 595
Resveratrol protects against global cerebral ischemic injury in gerbils
Wang, Q., Xu, J., Rottinghaus, G. E., Simonyi, A., Lubahn, D., Sun, G. Y., & Sun, A. Y. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03543-6 · Cited by 527
Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area.
Orgogozo, J. M., Dartigues, J. F., Lafont, S., Letenneur, L., Commenges, D., Salamon, R., Renaud, S., & Breteler, M. M. B. (1997) · PubMed · Cited by 523
Protein kinase C: poised to signal
Newton, A. C. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00477.2009 · Cited by 512
Karuppagounder, S. S., Pinto, J. T., Xu, H., Chen, H.-L., Beal, M. F., & Gibson, G. E. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2008.10.008 · Cited by 485
Kennedy, D. O., Wightman, E. L., Reay, J. L., Lietz, G., Okello, E. J., Wilde, A., & Haskell, C. F. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28641 · Cited by 415
Neuroprotective strategies involving ROS in Alzheimer disease
Dumont, M., & Beal, M. F. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.026 · Cited by 402
Protective effect of resveratrol on β-amyloid-induced oxidative PC12 cell death
Jang, J. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00062-5 · Cited by 390
Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats
Jin, F., Wu, Q., Lu, Y.-F., Gong, Q.-H., & Shi, J.-S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.005 · Cited by 384
Anti-Inflammatory Responses of Resveratrol
Das, S., & Das, D. (2007) · Inflammation & Allergy-Drug Targets · doi:10.2174/187152807781696464 · Cited by 382
Sinha, K., Chaudhary, G., & Kumar Gupta, Y. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01691-0 · Cited by 354
Alcohol Intake and Risk of Dementia
Luchsinger, J. A., Tang, M., Siddiqui, M., Shea, S., & Mayeux, R. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52159.x · Cited by 345
Culmsee, C., monnig, J., Kemp, B. E., & Mattson, M. P. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:1:45 · Cited by 340
Bureau, G., Longpré, F., & Martinoli, M. ‐. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21503 · Cited by 334
Bastianetto, S., Zheng, W., & Quirion, R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703626 · Cited by 302
Self-citationBelguendouz, L., Fremont, L., & Linard, A. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00820-9 · Cited by 299
Ladiwala, A. R. A., Lin, J. C., Bale, S. S., Marcelino-Cruz, A. M., Bhattacharya, M., Dordick, J. S., & Tessier, P. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133108 · Cited by 297
Han, Y., Zheng, W., Bastianetto, S., Chabot, J., & Quirion, R. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705688 · Cited by 297
Self-citationResveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation
Feng, Y., Wang, X.-P., Yang, S.-G., Wang, Y.-J., Zhang, X., Du, X.-T., Sun, X.-X., Zhao, M., Huang, L., & Liu, R.-T. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.08.013 · Cited by 295
Resveratrol inhibits nitric oxide and TNF-α production by lipopolysaccharide-activated microglia
Bi, X. L., Yang, J. Y., Dong, Y. X., Wang, J. M., Cui, Y. H., Ikeshima, T., Zhao, Y. Q., & Wu, C. F. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2004.08.008 · Cited by 274
Zhang, F., Liu, J., & Shi, J.-S. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.043 · Cited by 264
Albani, D., Polito, L., Batelli, S., De Mauro, S., Fracasso, C., Martelli, G., Colombo, L., Manzoni, C., Salmona, M., Caccia, S., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06228.x · Cited by 260
Lee, M., Cho, T., Jantaratnotai, N., Wang, Y. T., McGeer, E., & McGeer, P. L. (2010) · The FASEB Journal · doi:10.1096/fj.09-149997 · Cited by 243
Resveratrol Mimics Ischemic Preconditioning in the Brain
Raval, A. P., Dave, K. R., & Perez-Pinzon, M. A. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600262 · Cited by 240
Crystal Structure of Quinone Reductase 2 in Complex with Resveratrol,
Buryanovskyy, L., Fu, Y., Boyd, M., Ma, Y., Hsieh, T.-C., Wu, J. M., & Zhang, Z. (2004) · Biochemistry · doi:10.1021/bi049162o · Cited by 236
Virgili, M., & Contestabile, A. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00820-x · Cited by 233
Candelario-Jalil, E., de Oliveira, A. C. P., Gräf, S., Bhatia, H. S., Hüll, M., Muñoz, E., & Fiebich, B. L. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-25 · Cited by 223
Chang, J., Rimando, A., Pallas, M., Camins, A., Porquet, D., Reeves, J., Shukitt-Hale, B., Smith, M. A., Joseph, J. A., & Casadesus, G. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.015 · Cited by 217
Protein kinase C pharmacology: refining the toolbox
Wu-zhang, A. X., & Newton, A. C. (2013) · Biochemical Journal · doi:10.1042/bj20130220 · Cited by 195
Shin, S. M., Cho, I. J., & Kim, S. G. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.058479 · Cited by 195
Molecular mechanisms of neuroprotection by two natural antioxidant polyphenols
Campos-Esparza, M. R., Sánchez-Gómez, M. V., & Matute, C. (2009) · Cell Calcium · doi:10.1016/j.ceca.2008.12.007 · Cited by 185
Bournival, J., Quessy, P., & Martinoli, M.-G. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9411-5 · Cited by 182
Obisesan, T. O., Hirsch, R., Kosoko, O., Carlson, L., & Parrott, M. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb01005.x · Cited by 173
Wightman, E. L., Reay, J. L., Haskell, C. F., Williamson, G., Dew, T. P., & Kennedy, D. O. (2014) · British Journal of Nutrition · doi:10.1017/s0007114514000737 · Cited by 168
Resveratrol: a cardioprotective substance
Wu, J. M., & Hsieh, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05854.x · Cited by 167
Frozza, R. L., Bernardi, A., Hoppe, J. B., Meneghetti, A. B., Matté, A., Battastini, A. M. O., Pohlmann, A. R., Guterres, S. S., & Salbego, C. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8401-2 · Cited by 165
Protein kinase C inhibits amyloid β‐peptide neurotoxicity by acting on members of the Wnt pathway
Garrido, J. L., Godoy, J., Alvarez, A., Bronfman, M., & Inestrosa, N. C. (2002) · The FASEB Journal · doi:10.1096/fj.02-0327fje · Cited by 163
Resveratrol protects against experimental stroke: Putative neuroprotective role of heme oxygenase 1
Sakata, Y., Zhuang, H., Kwansa, H. E., Koehler, R. C., & Doré, S. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.032 · Cited by 156
Protein quality control in Alzheimer's disease by the ubiquitin proteasome system
de Vrij, F. M. S., Fischer, D. F., VANLEEUWEN, F., & Hol, E. M. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.10.001 · Cited by 155
NRH:quinone reductase 2: An enzyme of surprises and mysteries
Vella, F., Ferry, G., Delagrange, P., & Boutin, J. A. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.019 · Cited by 153
The role of nutrition in Alzheimer’s disease: epidemiological evidence
Morris, M. C. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02735.x · Cited by 151
The role of astrocytes in the physiology and pathology of the central nervous system
Markiewicz, I., & Lukomska, B. (2006) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2006-1623 · Cited by 151
Luchsinger, J. A., Noble, J. M., & Scarmeas, N. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0057-8 · Cited by 142
Quincozes‐Santos, A., Bobermin, L. D., Latini, A., Wajner, M., Souza, D. O., Gonçalves, C., & Gottfried, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064372 · Cited by 137
Albani, D., Polito, L., & Forloni, G. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1215 · Cited by 131
Bellaver, B., de Souza, D. G., Souza, D. O., & Quincozes‐Santos, A. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.01.006 · Cited by 124
Synaptic targeting by Aβ oligomers (ADDLS) as a basis for memory loss in early Alzheimer's disease
Klein, W. L. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2005.11.003 · Cited by 123
The Role of Apoptotic Pathways in Alzheimers Disease Neurodegeneration and Cell Death
LeBlanc, A. C. (2005) · Current Alzheimer Research · doi:10.2174/156720505774330573 · Cited by 115
Sato, M., Suzuki, Y., Okuda, T., & Yokotsuka, K. (1997) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.61.1800 · Cited by 115
Aisen, P. S. S. (2005) · CNS Drugs · doi:10.2165/00023210-200519120-00002 · Cited by 113
Wengreen, H. J. (2003) · PubMed · Cited by 109
Kwon, K. J., Kim, H.-J., Shin, C. Y., & Han, S. (2010) · Journal of Clinical Neurology · doi:10.3988/jcn.2010.6.3.127 · Cited by 106
New polyphenols active on β-amyloid aggregation
Rivière, C., Richard, T., Vitrac, X., Mérillon, J., Valls, J., & Monti, J. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.028 · Cited by 105
Ménard, C., & Quirion, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028666 · Cited by 104
Self-citationInduction of Apoptosis Is Driven by Nuclear Retention of Protein Kinase Cδ
Seimon, T. A., Ohm, A. M., Humphries, M. J., & Reyland, M. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703661200 · Cited by 102
Richard, T., Poupard, P., Nassra, M., Papastamoulis, Y., Iglésias, M., Krisa, S., Waffo‐Téguo, P., Mérillon, J., & Monti, J. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.04.001 · Cited by 98
Ménard, C., Bastianetto, S., & Quirion, R. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00281 · Cited by 94
Self-citationSpecific Plasma Membrane Binding Sites for Polyphenols, Including Resveratrol, in the Rat Brain
Han, Y.-S., Bastianetto, S., Dumont, Y., & Quirion, R. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.102319 · Cited by 92
Self-citationMeng, X., Yang, J., Chen, G., Wang, L., Zhang, L., Wang, S., Li, J., & Wu, C. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.04.015 · Cited by 87
Zamin, L. L., Dillenburg-Pilla, P., Comiran, R. A., Horn, A. P., Simão, F., Nassif, M., Gerhardt, D., Frozza, R. L., & Salbego, C. G. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.002 · Cited by 84
β-secretase (BACE1)-inhibiting stilbenoids from Smilax Rhizoma
Jeon, S. Y., Kwon, S.-H., Seong, Y. H., Bae, K., Hur, J.-M., Lee, Y.-Y., Suh, D., & Song, K. S. (2006) · Phytomedicine · doi:10.1016/j.phymed.2006.09.003 · Cited by 81
Das, S., Tósaki, Á., Bagchi, D., Maulik, N., & Das, D. K. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084285 · Cited by 76
ADDLs & protofibrils —the missing links?
Klein, W. L. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00312-8 · Cited by 75
Granzotto, A., & Zatta, P. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021565 · Cited by 75
Rapid solid-phase extraction and analysis of resveratrol and other polyphenols in red wine
Hashim, S. N. N. S., Schwarz, L. J., Boysen, R. I., Yang, Y., Danylec, B., & Hearn, M. T. W. (2013) · Journal of Chromatography A · doi:10.1016/j.chroma.2013.06.052 · Cited by 72
Kim, Y. A., Kim, G., Park, K.-Y., & Choi, Y. H. (2007) · Journal of Medicinal Food · doi:10.1089/jmf.2006.143 · Cited by 70
Cherniack, E. P. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512000669 · Cited by 68
Loss of Quinone Reductase 2 Function Selectively Facilitates Learning Behaviors
Benoit, C.-É., Bastianetto, S., Brouillette, J., Tse, Y. C., Boutin, J. A., Delagrange, P., Wong, T. P., Sarret, P., & Quirion, R. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2808-10.2010 · Cited by 59
Self-citationBastianetto, S., Brouillette, J., & Quirion, R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9333-x · Cited by 57
Self-citationYu, W., Mechawar, N., Krantic, S. M., & Quirion, R. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090496 · Cited by 57
Self-citationOld and new inhibitors of quinone reductase 2
Ferry, G., Hecht, S., Berger, S., Moulharat, N., Cogé, F., Guillaumet, G., Leclerc, V., Yous, S., Delagrange, P., & Boutin, J. A. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.04.006 · Cited by 56
Zhang, J., Feng, X., Wu, J., Xu, H., Li, G., Zhu, D., Yue, Q., Liu, H., Zhang, Y., Sun, D., et al. (2014) · BioFactors · doi:10.1002/biof.1149 · Cited by 50
Resveratrol is neuroprotective because it is not a direct activator of Sirt1—A hypothesis
Tang, B. L. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.12.007 · Cited by 45
Possible Involvement of Programmed Cell Death Pathways in the Neuroprotective Action of Polyphenols
Bastianetto, S., Krantic, S. M., Chabot, J., & Quirion, R. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391854 · Cited by 42
Self-citationYang, H., Pan, J., Ba, M., Sun, Z., Ma, G., Lü, G., Xiao, Q., & Chen, S. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05648.x · Cited by 40
Gong, Q., Wang, Q., Shi, J., Xie-nan, H., Liu, Q., & Ma, H. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00666.x · Cited by 39
Huang, T., Gao, D., Jiang, X., Hu, S., Zhang, L., & Fei, Z. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2239 · Cited by 35
Gao, D., Huang, T., Jiang, X., Hu, S., Zhang, L., & Fei, Z. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2086 · Cited by 35
Evidence for circulatory benefits of resveratrol in humans
Wong, R. H. X., Coates, A. M., Buckley, J. D., & Howe, P. R. C. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12155 · Cited by 32
Presenilin dependence of phospholipase C and protein kinase C signaling
Dehvari, N., Cedazo-Mínguez, Á., Isacsson, O., Nilsson, T., Winblad, B. G., Karlström, H., Benedikz, E., & Cowburn, R. F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04571.x · Cited by 16
Cited by
Resveratrol: A Double-Edged Sword in Health Benefits
Salehi, B., Mishra, A. P., Nigam, M., Sener, B., Kilic, M., Sharifi-Rad, M., Fokou, P. V. T., Martins, N., & Sharifi-Rad, J. (2018) · Biomedicines · doi:10.3390/biomedicines6030091 · Cited by 1,129
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
Turner, R. S., Thomas, R. G., Craft, S., van Dyck, C. H., Mintzer, J., Reynolds, B. A., Brewer, J. B., Rissman, R. A., Raman, R., Aisen, P. S., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002035 · Cited by 736
Diet and the Microbiota–Gut–Brain Axis: Sowing the Seeds of Good Mental Health
Berding, K., Vlckova, K., Marx, W., Schellekens, H., Stanton, C., Clarke, G., Jacka, F., Dinan, T. G., & Cryan, J. F. (2021) · Advances in Nutrition · doi:10.1093/advances/nmaa181 · Cited by 451
Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1
Gomes, B. A. Q., Silva, J. P. B., Romeiro, C. F. R., dos Santos, S. M., Rodrigues, C. A., Gonçalves, P. R., Sakai, J. T., Mendes, P. F. S., Varela, E. L. P., & Monteiro, M. C. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8152373 · Cited by 403
Resveratrol and diabetes: from animal to human studies
Szkudelski, T., & Szkudelska, K. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.013 · Cited by 354
Metadata
- Authors
- Bastianetto, S., Ménard, C., & Quirion, R.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 1852
- Issue
- 6
- Pages
- 1195-1201
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W2038062287
- Cited by
- 407
- References
- 100
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.